References
- LeeAMcCluskeyPClinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionClin Ophthalmol2010474176420689791
- DukerJSYanoffMOphthalmology3rd edEdinburgh, UKMosby2009
- QuigleyHGlaucomaLancet20113771367137721453963
- PapaconstantinouDGeorgalasIKourtisNPreliminary results following the use of a fixed combination of timolol-brimonidine in patients with ocular hypertension and primary open-angle glaucomaClin Ophthalmol2009322723019668570
- García-SánchezJRoulandJFSpiegelDA comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in EuropeBr J Ophthalmol20048887783315205229
- HigginbothamEConsideration in glaucoma therapy: fixed combinations versus their component medicationsClin Ophthalmol201041920169043
- FechtnerRHarasymowyczPNixonDTwelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprostClin Ophthalmol2011594595321792284
- GordonMOBeiserJABrandtJDThe Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucomaArch Ophthalmol200212071472012049575
- LeskeMHeijlAHusseinMFactors for glaucoma progression and the effect of treatment: The Early Manifest Glaucoma TrialArch Ophthalmol2003121485612523884
- TannaARademakerAStewartWMeta-analysis of the efficacy and safety of α2-adrenergic agonists, β-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogsArch Ophthalmol201012882583320625041
- LanzlIRaberTEfficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practiceClin Ophthalmol2011529129821468336
- Baiza-DuránLÁlvarez-DelgadoJContreras-RubioAThe efficacy and safety of two fixed combinations: timolol-dorzolamide-brimonidine versus timolol-dorzolamide. A prospective, randomized, double masked, multi-center, 6-month clinical trialAnn Ophthalmol (Skokie)20094117417820214051
- McKinnonSJGoldbergLDPeeplesPCurrent management of glaucoma and the need for complete therapyAm J Manag Care200814S20S2718284312
- OlthoffCSchoutenJVan de BorneBNoncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based reviewOphthalmology200511295396115885795